ReproNovo ApS
CVR 44291908 · Private limited company (ApS) · Active · Low risk
ReproNovo ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.8m and a net result of DKK 1.5m. CEO: Joan Carles Arce Saez.
Bankruptcy risk for ReproNovo ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44291908
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- c/o Joan Carles Arce Saez, Amagerfælledvej 106
2300 København S - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Auditor
- Ecovis Danmark statsautoriseret revisionsinteressentskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 16.0% |
| Current ratio | 139% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 48 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | – | DKK 32.4m |
| Gross profit | DKK 18.9m | DKK 14.8m |
| Net profit | DKK 1.5m | DKK 1.2m |
| Equity | DKK 2.8m | DKK 1.3m |
| Total assets | DKK 17.3m | DKK 6.0m |
| Cash | DKK 6.3m | DKK 3.8m |
| Short-term debt | DKK 12.3m | DKK 4.8m |
| Tax owed | DKK 228k | DKK 330k |
| Avg. employees | 10 | 10 |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Ecovis Danmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 182 | ||
| 7 Sep 2023 – 31 Dec 2024 | 183 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Joan Carles Arce Saez | Current | |
| Board | Joan Carles Arce Saez | Current | |
| Board | Jean Marie Duvall | Current | |
| Board | BingMei Hao | Current | |
| Owner (100%) | ReproNovo SA | Current | |
| Auditor | Ecovis Danmark statsautoriseret revisionsinteressentskab | Current | |
| Founder | ReproNovo SA | Current |
The CEOs' other companies
Joan Carles Arce Saez – 1 other companies
- ReproStart ApS Active
Address history (1 moves)
| c/o Joan Carles Arce Saez, Amagerfælledvej 106, 2300 København S | |
| c/o Joan Carles Arce Saez, Amagerfælledvej 106, 2300 København S |
Other companies at the same address
- 0xTHREE ApS Bankrupt
- Appstract Consulting ApS Bankrupt
- Bancore A/S Bankrupt
- European Institute of Innovation, Entrepreneurship, and Technology ApS Bankrupt
- JBRD Komplementar ApS Bankrupt
- PENTAMARK GROUP IVS Bankrupt
- Paytech Invest A/S Bankrupt
- Selskabet af 13.10.2015 ApS Bankrupt
- Talentiir ApS Bankrupt
- ALLERGYCERTIFIED ApS Active
- Acentio A/S Active
- Alcora ApS Active
- Ardoq Denmark ApS Active
- Checkin ApS Active
- Cliio ApS Active
- Crypta ApS Opløst
- DIAKRIT DANMARK ApS Active
- Daiichi Sankyo Nordics ApS Active
- Elaway ApS Active
- EyeReply ApS Active
- FISCHER & KERRN A/S Active
- Feedr ApS Active
- Get Lit Denmark ApS Active
- Get Lit Holding ApS Active
- HverdagsAI ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about ReproNovo ApS
Has ReproNovo ApS gone bankrupt?
No, ReproNovo ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of ReproNovo ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of ReproNovo ApS?
Joan Carles Arce Saez is the CEO of ReproNovo ApS.
Who is the auditor of ReproNovo ApS?
ReproNovo ApS most recently used Ecovis Danmark statsautoriseret revisionsinteressentskab.
When was ReproNovo ApS founded?
ReproNovo ApS was founded on 7 September 2023.
What is the equity of ReproNovo ApS?
Equity was DKK 2.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.